Associated Papers
Molecular characterization and therapeutic reaction to dasatinib in a CML patient harboring a novel e8a2 BCR-ABL1 transcript with a somatic mutation in TP53BP2 and cadherin-10 genes.
Zhang Y et al.
Leukemia & Lymphoma, 2018
Select a paper to view details